Galectin Therapeutics (GALT) Earnings Call Presentation
Galectin Therapeutics(US:GALT)2025-06-16 20:26Belapectin for MASH Cirrhosis and Portal Hypertension 2 Company introduction Joel Lewis CEO & President June 2025 Today's Agenda | 01 | Moderator Michael Cozart, LifeSci Consulting | | --- | --- | | 02 | Galectin Company Introduction Joel Lewis (CEO & President) | | 03 | Belapectin as Galectin-3 Inhibitor for MASH cirrhosis & Portal Hypertension Khurram Jamil, M.D. (CMO) | | 04 | Unmet Need & Patient Landscape Naga Chalasani, M.D. | | 05 | Khurram | | | Clinical Results – NAVIGATE Trial design & Results Nai ...